Aspiriant Holdings S3’s Raytheon Company RTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
$4.81M Sell
38,612
-419
-1% -$50.4K 2.07% 11
2015
Q3
$4.26M Sell
39,031
-440
-1% -$46K 1.97% 12
2015
Q2
$3.78M Sell
39,471
-15,364
-28% -$1.61M 1.51% 24
2015
Q1
$5.99M Buy
54,835
+790
+1% +$84.9K 2.38% 8
2014
Q4
$5.85M Buy
54,045
+1,980
+4% +$204K 2.41% 9
2014
Q3
$5.29M Buy
52,065
+38,835
+294% +$3.72M 2.12% 12
2014
Q2
$1.22M Buy
13,230
+670
+5% +$65K 0.49% 59
2014
Q1
$1.24M Sell
12,560
-581
-4% -$55.1K 0.52% 56
2013
Q4
$1.19M Sell
13,141
-305
-2% -$25.5K 0.47% 58
2013
Q3
$1.04M Sell
13,446
-1,738
-11% -$129K 0.44% 59
2013
Q2
$1M Buy
+15,184
New +$960K 0.45% 59

Other funds holding RTN

Aspiriant Holdings S3's RTN Position: Q4 2015 in Review

Aspiriant Holdings S3 reduced its Raytheon Company (RTN) stake by 1.1% in Q4 2015, selling an estimated $50.4K and leaving 38,612 shares worth $4.81M. The position accounts for 2.07% of the portfolio, ranked #11.

Aspiriant Holdings S3 first reported a position in RTN in Q2 2013 and has held it in 11 quarters since. The position peaked at $5.99M in Q1 2015. 934 funds tracked by Wall St. Rank hold RTN as of Q4 2015.

  • Aspiriant Holdings S3 held 38,612 shares of Raytheon Company worth $4.81M as of Q4 2015.
  • Aspiriant Holdings S3 sold 419 Raytheon Company shares in Q4 2015, an estimated $50.4K.
  • Raytheon Company made up 2.07% of Aspiriant Holdings S3's portfolio in Q4 2015, its #11 holding.
  • Aspiriant Holdings S3 first reported a position in Raytheon Company in Q2 2013 and has held it in 11 quarters since.
  • Aspiriant Holdings S3's Raytheon Company position peaked at $5.99M in Q1 2015.
  • 934 funds tracked by Wall St. Rank held Raytheon Company as of Q4 2015.

Based on Aspiriant Holdings S3's 13F filing for Q4 2015, filed 13 Jan 2016.